FindTrial
Sign In

Clinico-pathological study of Lichen Planus

A CLINICAL, HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY FOR CD4 AND CD8 T- LYMPHOCYTE SUBSETS IN LICHEN PLANUS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/04/003567
Enrollment
30
Registered
2013-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Cutaneous and oral lichen planus

Interventions

None listed

Sponsors

Teena Ramesh M
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both sexes aged 18 years and above. Patients willing for the required investigation with a written informed consent. Untreated, newly detected cases of lichen planus.

Exclusion criteria

Exclusion criteria: Patients not willing to give consent. Age less than 18 years. Immunocompromised patients and pregnant women. Patients who have taken treatment for lichen planus within the past three months.

Design outcomes

Primary

MeasureTime frame
clinical and histopathologicalprofile of patients with lichen planusTimepoint: 1 year—

Secondary

MeasureTime frame
Immunohistochemical analysis for CD4+ and CD8+ T-cell subsetsTimepoint: 1 year—

Countries

India

Contacts

Public ContactTeena Ramesh M

Father Muller Medical College Hospital

rameshderma@gmail.com9845084224

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026